SOD2 and brain disorder: One promising gene therapy strategy involves the delivery of genes encoding mitochondrial-targeted antioxidants, such as manganese superoxide dismutase (MnSOD) or catalase, to counteract the elevated reactive oxygen species (ROS) levels observed in brain disease [436].